In: Vaccines, 2021, vol. 9, no. 9, p. 7
Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase with COVID-19 vaccines (of any technologies) than with other viral vaccines, over the full...
|
In: Cancers, 2020, vol. 12, no. 11, p. 15
Up to 50% of myocarditis events developed in cancer patients upon treatment with immune checkpoint inhibitors (ICIs) are fatal. Therefore, identification of clinical risk factors predicting myocarditis onset during treatment with ICIs is important for the purpose of cardiac surveillance of high-risk patients. The aim of this retrospective matched case-control study was to assess whether...
|
In: Endocrine, 2020, p. 7 p
The length of time a critically ill coronavirus disease 2019 (COVID-19) patient remains infectious and should therefore be isolated remains unknown. This prospective study was undertaken in critically ill patients to evaluate the reliability of single negative real-time polymerase chain reaction (RT-PCR) in lower tracheal aspirates (LTA) in predicting a second negative test and to analyze...
|
In: European Journal of Pediatrics, 2014, vol. 173, no. 6, p. 743-750
|
In: European Journal of Clinical Pharmacology, 2012, vol. 68, no. 8, p. 1209-1219
|
In: European Journal of Clinical Pharmacology, 2011, vol. 67, no. 1, p. 97-99
|
